Cromolyn sodium can inhibit the promoting effect of PD-1 antibody on mast cell degranulation in vivo and in vitro, thus inhibiting the negative effect of mast cells in the tumor microenvironment and improving the efficacy of immunotherapy. The gene discussed is PDCD1; the disease is neoplasm.